Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The cytoplasmic side of p53's oncosuppressive activities
Anna Comel, Giovanni Sorrentino, Valeria Capaci, et al.
FEBS Letters (2014) Vol. 588, Iss. 16, pp. 2600-2609
Closed Access | Times Cited: 118

Showing 26-50 of 118 citing articles:

Autophagy regulates UBC9 levels during viral-mediated tumorigenesis
Domenico Mattoscio, Chiara Casadio, Claudia Miccolo, et al.
PLoS Pathogens (2017) Vol. 13, Iss. 3, pp. e1006262-e1006262
Open Access | Times Cited: 56
Wild type- and mutant p53 proteins in mitochondrial dysfunction: emerging insights in cancer disease
Giovanni Blandino, Fabio Valenti, Andrea Sacconi, et al.
Seminars in Cell and Developmental Biology (2019) Vol. 98, pp. 105-117
Closed Access | Times Cited: 47
Repression of p53 function by SIRT5-mediated desuccinylation at Lysine 120 in response to DNA damage
Xing Liu, Fangjing Rong, Jinhua Tang, et al.
Cell Death and Differentiation (2021) Vol. 29, Iss. 4, pp. 722-736
Open Access | Times Cited: 40
MicroRNAs as Key Effectors in the p53 Network
Frauke Goeman, Sabrina Strano, Giovanni Blandino
International review of cell and molecular biology (2017), pp. 51-90
Closed Access | Times Cited: 44
FOXO3–NF-κB RelA Protein Complexes Reduce Proinflammatory Cell Signaling and Function
Matthew G. Thompson, Michelle Larson, Amy Vidrine, et al.
The Journal of Immunology (2015) Vol. 195, Iss. 12, pp. 5637-5647
Open Access | Times Cited: 42
Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cells
Nataly Melo dos Santos, Guilherme A. P. de Oliveira, Murilo Ramos Rocha, et al.
Journal of Biological Chemistry (2019) Vol. 294, Iss. 24, pp. 9430-9439
Open Access | Times Cited: 42
SUMOylation and phosphorylation cross-talk in hepatocellular carcinoma
Maria Lauda Tomasi, Komal Ramani
Translational Gastroenterology and Hepatology (2018) Vol. 3, pp. 20-20
Open Access | Times Cited: 39
Molecular Determinants of Cancer Therapy Resistance to HDAC Inhibitor-Induced Autophagy
Maria Mrakovcic, Leopold F. Fröhlich
Cancers (2019) Vol. 12, Iss. 1, pp. 109-109
Open Access | Times Cited: 36
Autophagy: A Friend or Foe in Allergic Asthma?
Efthymia Theofani, Georgina Xanthou
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6314-6314
Open Access | Times Cited: 30
Mutant p53 elicits context-dependent pro-tumorigenic phenotypes
Jennifer J. McCann, Irina A. Vasilevskaya, Christopher McNair, et al.
Oncogene (2021) Vol. 41, Iss. 3, pp. 444-458
Open Access | Times Cited: 28
Natural products targeting signaling pathways associated with regulated cell death in gastric cancer: Recent advances and perspectives
Qichao Hu, Zhibei Li, Yubing Li, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 6, pp. 2661-2692
Closed Access | Times Cited: 12
Targeting autophagy can synergize the efficacy of immune checkpoint inhibitors against therapeutic resistance: New promising strategy to reinvigorate cancer therapy
Mehrdad Hashemi, Elaheh Mohandesi Khosroshahi, Mahsa Tanha, et al.
Heliyon (2024) Vol. 10, Iss. 18, pp. e37376-e37376
Open Access | Times Cited: 4
A nanobody modulates the p53 transcriptional program without perturbing its functional architecture
Jonas Bethuyne, Steven De Gieter, Olivier Zwaenepoel, et al.
Nucleic Acids Research (2014) Vol. 42, Iss. 20, pp. 12928-12938
Open Access | Times Cited: 36
Constitutive p53 heightens mitochondrial apoptotic priming and favors cell death induction by BH3 mimetic inhibitors of BCL-xL
Janic Le Pen, M Laurent, Kristopher A. Sarosiek, et al.
Cell Death and Disease (2016) Vol. 7, Iss. 2, pp. e2083-e2083
Open Access | Times Cited: 36
Role of Asparagine Endopeptidase in Mediating Wild-Type p53 Inactivation of Glioblastoma
Yingying Lin, Keman Liao, Yifeng Miao, et al.
JNCI Journal of the National Cancer Institute (2019) Vol. 112, Iss. 4, pp. 343-355
Open Access | Times Cited: 35
Otub1 stabilizes MDMX and promotes its proapoptotic function at the mitochondria
Yingxiao Chen, Yue-Gang Wang, Yuhuang Li, et al.
Oncotarget (2016) Vol. 8, Iss. 7, pp. 11053-11062
Open Access | Times Cited: 34
Research Progress and Prospects of Autophagy in the Mechanism of Multidrug Resistance in Tumors
Wenqing Long, Lijun Zhang, Yuxing Wang, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 18
The role of autophagy in cancer: from molecular mechanism to therapeutic window
Pooya Jalali, Arvin Shahmoradi, Amir Samii, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Inflammasomes and autophagy in cancer: unlocking targeted therapies
Jitendra Gupta, Mohammed H. Mohammed, Tawfeeq Alghazali, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Regulation of mitochondrial apoptosis by Pin1 in cancer and neurodegeneration
Giovanni Sorrentino, Anna Comel, Fiamma Mantovani, et al.
Mitochondrion (2014) Vol. 19, pp. 88-96
Closed Access | Times Cited: 34
TAT-ODD-p53 enhances the radiosensitivity of hypoxic breast cancer cells by inhibiting Parkin-mediated mitophagy
Rong Zheng, Qiwei Yao, Guozhu Xie, et al.
Oncotarget (2015) Vol. 6, Iss. 19, pp. 17417-17429
Open Access | Times Cited: 33
Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy
Nastasia Wilfinger, Shane Austin, Barbara Scheiber‐Mojdehkar, et al.
Oncotarget (2015) Vol. 7, Iss. 2, pp. 1242-1261
Open Access | Times Cited: 30
Wild-type and cancer-related p53 proteins are preferentially degraded by MDM2 as dimers rather than tetramers
Chen Katz, Ana María Low-Calle, Joshua H. Choe, et al.
Genes & Development (2018) Vol. 32, Iss. 5-6, pp. 430-447
Open Access | Times Cited: 30
Effect of the BH3 Mimetic Polyphenol (–)-Gossypol (AT-101) on the in vitro and in vivo Growth of Malignant Mesothelioma
Monica Benvenuto, Rosanna Mattera, Joshua Ismaele Sticca, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 29
HOPS/TMUB1 retains p53 in the cytoplasm and sustains p53‐dependent mitochondrial apoptosis
Marilena Castelli, Danilo Piobbico, Martina Chiacchiaretta, et al.
EMBO Reports (2019) Vol. 21, Iss. 2
Open Access | Times Cited: 27

Scroll to top